This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB06841/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/resource/drugbank/drug/DB06841/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06841/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB06841/identifier/pubchem-substance/

Statements

Subject Item
n2:DB06841
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB06841 n12:DB06841
dcterms:title
D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide
adms:identifier
n4:0G6 n9:46937029 n10:99443312 n13:DB06841
n5:IUPAC-Name
n6:271B5711-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5717-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5716-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5713-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5714-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5715-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B570F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B570D-363D-11E5-9242-09173F13E4C5 n6:271B5710-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B570E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B571D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B571E-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5718-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5719-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B571B-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B571A-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B571C-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5723-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5725-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5726-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5722-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5721-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5724-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5712-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B571F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5720-363D-11E5-9242-09173F13E4C5